Advances in Managing Chronic Rhinosinusitis with Nasal Polyps: Practice-Changing Pearls for the Clinician

Friday, February 24, 2023

9:30 PM – 10:30 PM EST Symposium
8:30 PM – 9:30 PM CST
7:30 PM – 8:30 PM MST
6:30 PM – 7:30 PM PST


  • Interactive case-based learning objective
  • Simulation challenge and whiteboard animations
  • Create your own personalized poster

Learning Objectives

  • Describe the etiopathogenesis of CRSwNP as a foundation for informed treatment decision-making.
  • Discuss data from clinical trials assessing the efficacy, safety, and tolerability of available and emerging therapeutic options for patients with CRSwNP.
  • Identify patients who may benefit from biologic therapies for treatment of CRSwNP.

Target Audience

This activity is designed to meet the educational needs of allergists, immunologists, otolaryngologists, primary care physicians, nurses, nurse practitioners, pharmacists, and other members of the multidisciplinary team to ensure an up-to-date understanding of the latest data in management of CRSwNP.

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

Physician Credit Designation Statement

Med Learning Group designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

Joint Accreditation Statement

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education ACCME, the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nurses (ANCC) Credit Designation

Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hours.

Disclosure Policy Statement

In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Disclosure Of Unlabeled Use

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.


Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at:


Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at

This activity is provided by Med Learning Group
This activity is co-provided by AMEDCO.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi

Release date: February 24, 2023
Expiration date: February 24, 2024
Estimated time to completion: 1.0 hour